SurgePays, Inc.

SURG · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Valuation
PEG Ratio-0.330.410.02-0.01
FCF Yield-8.33%-9.89%-16.76%-22.11%
EV / EBITDA-9.26-10.37-5.59-1.45
Quality
ROIC-116.63%-67.38%-63.68%-91.04%
Gross Margin-13.90%-23.05%-27.82%-117.04%
Cash Conversion Ratio0.620.860.910.40
Growth
Revenue 3-Year CAGR-29.05%-36.60%-33.35%-20.58%
Free Cash Flow Growth24.07%12.13%11.83%42.94%
Safety
Net Debt / EBITDA-1.37-0.870.180.37
Interest Coverage-16.37-24.38-63.47-95.68
Efficiency
Inventory Turnover11.105.887.5911.69
Cash Conversion Cycle-7.323.827.9818.86